BRIEF-Biomarin provides program update on Vosoritide in Achondroplasia By: Reuters: Company News April 20, 2016 at 10:41 AM EDT * Biomarin provides program update on Vosoritide in Achondroplasia Read More >> Related Stocks: Biomarin Pharmaceuticals